Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is -25.80% vs -2.01% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is -139.62% vs 65.62% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is -15.28% vs 4.22% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is 6.86% vs -3.77% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Compare Quarterly Results Of Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2026 is -14.33% vs 8.07% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -25.80% vs -2.01% in Jun 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is -123.08% vs -1.09% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -139.62% vs 65.62% in Jun 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2026 is -16.59% vs 19.26% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -15.28% vs 4.22% in Jun 2025
Quarterly - Interest
QoQ Growth in quarter ended Jun 2026 is 4.81% vs -0.48% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 6.86% vs -3.77% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025






